Revenue by source
Consumables$972.29MBiotechnology$0.00Instruments$112.09MClinical Controls$0.00Royalty$23.69MHematology$0.00
| Segment | 2012 | 2013 | 2014 | 2023 | 2024 | 2025 |
|---|
| Consumables | - | - | - | $917.73M | $928.18M | $972.29M |
| Biotechnology | $293.27M | $288.16M | $300.58M | - | - | - |
| Instruments | - | - | - | $112.09M | $108.27M | $112.09M |
| Clinical Controls | - | $22.42M | $57.19M | - | - | - |
| Royalty | - | - | - | $21.10M | $23.35M | $23.69M |
| Hematology | $21.29M | - | - | - | - | - |
Revenue by country
U S$683.23MEurope$266.31MC N$100.46MAPAC, excluding Greater China$77.26MRest Of World$37.55MUnited Kingdom$0.00Other Asia$0.00UNITED KINGDOM$54.83M
| Segment | 2012 | 2013 | 2014 | 2023 | 2024 | 2025 |
|---|
| U S | $172.31M | $164.31M | $190.36M | $642.47M | $657.75M | $683.23M |
| Europe | $90.14M | $88.30M | $97.16M | $220.23M | $241.43M | $266.31M |
| C N | $11.38M | $14.11M | $18.88M | $113.87M | $99.47M | $100.46M |
| APAC, excluding Greater China | - | - | - | $73.19M | $73.90M | $77.26M |
| Rest Of World | $14.74M | $15.26M | $18.67M | $37.49M | $36.50M | $37.55M |
| United Kingdom | - | - | - | $49.46M | $50.01M | - |
| Other Asia | $25.99M | $28.61M | $32.70M | - | - | - |
| UNITED KINGDOM | - | - | - | - | - | $54.83M |